Drug Name: Paxlovid
Indications: To treat mild-to-moderate COVID-19 in adults at high risk for progression to severe COVID-19.
Active Ingredient: Nirmatrelvir, Ritonavir
Company: Pfizer Labs
Approval Date: 5/25/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217188s000lbl.pdf